| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/2004 | US20040077576 Without integration into host genome; cassette sequence and direction independent |
| 04/22/2004 | US20040077575 Inhibition of pathological angiogenesis in vivo |
| 04/22/2004 | US20040077574 Protein tyrosine phosphatase inhibitors |
| 04/22/2004 | US20040077573 Suppresses overexpression; reducing side effects; such as preventing occurance of plethora while treating anemia with erythropoietin |
| 04/22/2004 | US20040077572 Polynucleotide or complement comprising nucleic acid sequence flanked by first and second inverted repeats |
| 04/22/2004 | US20040077571 Such as oligonucleotides with phosphorothioate backbones |
| 04/22/2004 | US20040077569 Hybridizes with and inhibits expression of nucleic acid molecule encoding alternatively spliced or truncated form; hyperproliferative disorders |
| 04/22/2004 | US20040077565 Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
| 04/22/2004 | US20040077547 Preventing catalytic conversion of factors X, VII AND IX to Xa, VIIa and IXa respectively |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077526 SR-BI antagonist and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 04/22/2004 | US20040077090 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/22/2004 | US20040077089 Vectors for conditional gene inactivation |
| 04/22/2004 | US20040077088 In particular techniques for deriving bone structure, bone strength, and risk of fracture |
| 04/22/2004 | US20040077085 Antisense modulation of CDC14A expression |
| 04/22/2004 | US20040077084 Antisense modulation of histone deacetylase 4 expression |
| 04/22/2004 | US20040077083 For treatment of diseases associated with expression of Histone deacetylase 4 such as leukemia |
| 04/22/2004 | US20040077082 Oligonucleotides with 5'- and 3'-terminal hairpins that may be configured to regulate the expression of a gene |
| 04/22/2004 | US20040077080 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/22/2004 | US20040077078 Novel human membrane proteins |
| 04/22/2004 | US20040077077 Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same |
| 04/22/2004 | US20040077069 Method for the production of a heterologous protein by a fungus |
| 04/22/2004 | US20040077068 Carotenoid production from a single carbon substrate |
| 04/22/2004 | US20040077067 Therapeutic and prophylactic agents derived from aeromonas hydrophila bacterial surface proteins |
| 04/22/2004 | US20040077066 Purified active HCV NS2/3 protease |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077058 Domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed |
| 04/22/2004 | US20040077056 By culturing a Shingomonas bacteria in a fermentation broth for a time and temperature effective for providing a sphingan exopolysaccharide in a slime form |
| 04/22/2004 | US20040077053 Methods to identify growth differentiation factor (GDF) receptors |
| 04/22/2004 | US20040077052 Human cytokine receptor |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077050 Heliothis glutamate receptor |
| 04/22/2004 | US20040077047 Allows efficient production of heterologous protein and wherein any contamination of the product protein by vegetative spores is avoided |
| 04/22/2004 | US20040077046 Histone deacetylase-related gene and protein |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077043 Novel dendritic cell wall membrane and use thereof |
| 04/22/2004 | US20040077042 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 04/22/2004 | US20040077041 Gene products for preventing, ameliorating, correcting dysfunctions or diseases including obesity and diseases related to obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorders, |
| 04/22/2004 | US20040077040 Incorporation into a vector and expressing of the SBAmyB or SBAmyC gene of the sugar beet and recovering the product of the expressed gene |
| 04/22/2004 | US20040077038 Methods for production of proteins in host cells |
| 04/22/2004 | US20040077029 Human protooncogene and protein encoded therein |
| 04/22/2004 | US20040077016 The bacteria are good research materials for investigating the interrelation between enzyme structures and functions since they are stable at extreme pH, crystallize easily and are easy- to-handle |
| 04/22/2004 | US20040077014 Kit for enhancing the association rates of polynucleotides |
| 04/22/2004 | US20040077013 DNA constructs, host cells and production methods for the expression and recovery of polypeptides altered to have glycosylation sites added or deleted; employ a DNA segment corresponding to a mammalian tissue plasminogen activator |
| 04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
| 04/22/2004 | US20040077008 Method and compositions for reversible inhibition of thermostable polymerases |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076998 Sequencing method using magnifying tags |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076996 Useful as a fully automatic gene analysis/diagnosis device which can be simplified in structure, made compact in size and light in weight, cheap and in which detection of various kinds of DNA can be conducted rapidly and with precision |
| 04/22/2004 | US20040076995 Finding that the Nurr1 transciption factor, which forms a heterodimer with the retinoid X receptor, can be mutated in the I box region such that dimerisation does not occur while Nurr1 transcriptional activation activity is retained |
| 04/22/2004 | US20040076994 Method of detecting target nucleic acid and nucleic acid probe |
| 04/22/2004 | US20040076993 Novel calcium-independent phospholipases a2, genes thereof and promoter of the same |
| 04/22/2004 | US20040076992 Novel cell adhesion molecule specific to activated leukocyte |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076990 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 04/22/2004 | US20040076988 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076983 Ligand detection method |
| 04/22/2004 | US20040076982 3-hydroxypropionic acid and other organic compounds |
| 04/22/2004 | US20040076980 Method of separating extra-chromosonal dna from other cellular components |
| 04/22/2004 | US20040076977 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 04/22/2004 | US20040076976 Aopb gene, protein,homologs, fragments and variants thereof, and their use for cell surface display |
| 04/22/2004 | US20040076975 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 04/22/2004 | US20040076973 Oligonucleotide targeted to a nucleic acid molecule encoding ubiquitin protein ligase WWP1 or WWP2; hybridizes with and inhibits the expression of the ubiquitin protein ligase. |
| 04/22/2004 | US20040076972 Marking |
| 04/22/2004 | US20040076971 UV excitable fluorescent energy transfer dyes |
| 04/22/2004 | US20040076968 Method for detecting pre-disposition to hepatotoxicity |
| 04/22/2004 | US20040076966 Encapsulating a solution for in vitro transcription/ translation reactions so that the reactions proceed inside said capsule. |
| 04/22/2004 | US20040076963 Contacting the functionalized front surface of a metal substrate with linker molecules each having a group which binds to the surface (e.g., an alkoxysilane) and contacting the surface with probes to bind them to the front surface |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076954 Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters |
| 04/22/2004 | US20040076952 Reagent solution and DNA fragments serving as templates are continuously by heat-exchange fluids whose temperatures differ, enabling successive DNA amplification reactions to be carried out efficaciously in large volume |
| 04/22/2004 | US20040076951 Also antibodies, gene chips, transgenic non-human animals |
| 04/22/2004 | US20040076949 Methods for identifying inhibitors of helicase activity from hepatitis C virus |
| 04/22/2004 | US20040076635 Genetic vaccine, polypeptide encoded by a nucleotide sequence genome, a vector, a transgenic cell, for preventing and treating viral infections |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |
| 04/22/2004 | US20040076631 Treating infections caused by respiratory syncytial virus, transfected eukaryotic cells, isolating human B cells from transfected mouse, use for immunoassay, diagnosis the virus, test kits |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076626 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076622 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 04/22/2004 | US20040076621 An oligo- or poly-nucleotides is used to inhibit gene expression of antigen, therapeutic treatment of leukemia, atherosclerosis cardiovascular disorders |
| 04/22/2004 | US20040076613 Vector system |
| 04/22/2004 | US20040076612 For drug screening hepatitis C virus drugs |
| 04/22/2004 | US20040076610 Method of treating portal hypertension |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | DE10296800T5 Inhibitoren von Isoformen der DNA Methyltransferase Inhibitors of DNA methyltransferase isoforms of |
| 04/22/2004 | DE10136702B4 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells |
| 04/22/2004 | CA2823937A1 Hiv vaccine formulations |
| 04/22/2004 | CA2820949A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501941A1 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | CA2501939A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501875A1 Cap-binding protein |
| 04/22/2004 | CA2501872A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |